1) DNA methyltransferase inhibitors
DNA甲基转移酶抑制剂
1.
Progress in DNA methyltransferase inhibitors
DNA甲基转移酶抑制剂的研究进展
3) N-methyltransferase inhibitors
N-甲基转移酶抑制剂
4) DNA methyltransferase inhibitor
DNA甲基化酶抑制剂
1.
The co-effect of extracellular-signal regulated kinase mitogen-activated protein kinase signaling pathway inhibitor and DNA methyltransferase inhibitor on human colon cancer cells;
丝裂原激活蛋白激酶阻断剂与DNA甲基化酶抑制剂对人结肠癌细胞的协同影响
2.
Objective To investigate the effects of DNA methyltransferase inhibitor(DNMTi) and histone deacetylase inhibitor(HDCAi) on expression of E-cadherin gene and invasiveness of cholangiocarcinoma cell.
目的探讨联合使用DNA甲基化酶抑制剂(DNA methyltransferase inhibitor,DNMTi)和组蛋白脱乙酰化酶抑制剂(histone deacetylase inhibitor,HDACi)干预胆管癌细胞后,对E-cadherin基因的表达和细胞侵袭力的影响。
5) catechol-O-methyltransferase inhibitor
儿茶酚胺氧位甲基转移酶抑制剂
6) COMT inhibitor
儿茶酚氧位甲基转移酶抑制剂
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条